Q BioMed Inc (NASDAQ:QBIO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.
According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “
Q BioMed (NASDAQ QBIO) opened at 3.8754 on Wednesday. The firm’s 50-day moving average price is $4.03 and its 200-day moving average price is $4.28. The stock’s market cap is $40.85 million. Q BioMed has a 52 week low of $2.39 and a 52 week high of $12.61.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/08/23/q-biomed-inc-qbio-upgraded-to-hold-at-zacks-investment-research.html.
Q BioMed Company Profile
Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.
Receive News & Ratings for Q BioMed Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed Inc and related companies with MarketBeat.com's FREE daily email newsletter.
